Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200 | Journal of Clinical Oncology |
| 139 | 2005 |
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer? | Science |
| 320 | 2006 |
Neuropilins in neoplasms: Expression, regulation, and function | Experimental Cell Research |
| 191 | 2006 |
Towards third generation matrix metalloproteinase inhibitors for cancer therapy | British Journal of Cancer |
| 246 | 2006 |
Sunitinib: A newly approved small-molecule inhibitor of angiogenesis | Drugs of Today | 43 | 2006 |
Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
The dynamic microenvironment associated with metastatic bone disease: Current concepts | Journal of Surgical Oncology |
| 2023 | |
A novel cross-communication of HIF-1α and HIF-2α with Wnt signaling in TNBC and influence of hypoxic microenvironment in the formation of an organ-on-chip model of breast cancer | Medical Oncology |
| 1 | 2023 |
The Anti-angiogenic and Anti-microbial Effect of Diosmin: Potential Receptor Interactions via Molecular Docking | Revista Brasileira de Farmacognosia |
| 2023 | |
New indolizidine- and pyrrolidine-type alkaloids with anti-angiogenic activities from Anisodus tanguticus | Biomedicine & Pharmacotherapy |
| 2 | 2023 |
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy | Frontiers in Immunology |
| 11 | 2023 |